We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+5.81%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$13B
AUM Growth
+$984M
Cap. Flow
+$180M
Cap. Flow %
1.38%
Top 10 Hldgs %
38.14%
Holding
1,449
New
52
Increased
710
Reduced
341
Closed
132

Top Buys

Rank Stock Value
1
PLD icon
Prologis
PLD
+$287M
2
DLR icon
Digital Realty Trust
DLR
+$150M
3
HR icon
Healthcare Realty
HR
+$110M
4
WELL icon
Welltower
WELL
+$106M
5
O icon
Realty Income
O
+$88.1M

Sector Composition

Rank Sector Weight
1 Real Estate 57.53%
2 Technology 9.67%
3 Healthcare 4.73%
4 Financials 4.38%
5 Consumer Discretionary 3.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABSI icon
1226
Absci
ABSI
$1.21B
$1K ﹤0.01%
270
ABUS icon
1227
Arbutus Biopharma
ABUS
$871M
$1K ﹤0.01%
395
ACET icon
1228
Adicet Bio
ACET
$76.7M
$1K ﹤0.01%
7
ADAP
1229
DELISTED
Adaptimmune Therapeutics
ADAP
$1K ﹤0.01%
469
AFMD
1230
DELISTED
Affimed
AFMD
$1K ﹤0.01%
41
ANNX icon
1231
Annexon
ANNX
$814M
$1K ﹤0.01%
131
ATAI icon
1232
AtaiBeckley Inc
ATAI
$2.66B
$1K ﹤0.01%
468
AVIR icon
1233
Atea Pharmaceuticals
AVIR
$361M
$1K ﹤0.01%
242
BMEA icon
1234
Biomea Fusion
BMEA
$90.4M
$1K ﹤0.01%
109
CCCC icon
1235
C4 Therapeutics
CCCC
$393M
$1K ﹤0.01%
142
CDXS icon
1236
Codexis
CDXS
$161M
$1K ﹤0.01%
189
CGEM icon
1237
Cullinan Oncology
CGEM
$1.07B
$1K ﹤0.01%
127
CMPS
1238
Compass Pathways
CMPS
$1.46B
$1K ﹤0.01%
64
CNTA
1239
DELISTED
Centessa Pharmaceuticals
CNTA
$1K ﹤0.01%
+211
New +$782
CRBU icon
1240
Caribou Biosciences
CRBU
$148M
$1K ﹤0.01%
176
EOLS icon
1241
Evolus
EOLS
$410M
$1K ﹤0.01%
162
FHTX icon
1242
Foghorn Therapeutics
FHTX
$301M
$1K ﹤0.01%
+168
New +$1.27K
FULC icon
1243
Fulcrum Therapeutics
FULC
$248M
$1K ﹤0.01%
138
GBIO
1244
DELISTED
Generation Bio
GBIO
$1K ﹤0.01%
19
GLUE icon
1245
Monte Rosa Therapeutics
GLUE
$1.86B
$1K ﹤0.01%
136
GOSS icon
1246
Gossamer Bio
GOSS
$100M
$1K ﹤0.01%
260
HUMA icon
1247
Humacyte
HUMA
$170M
$1K ﹤0.01%
301
IGMS
1248
DELISTED
IGM Biosciences
IGMS
$1K ﹤0.01%
88
NBP
1249
NovaBridge Biosciences American Depositary Shares
NBP
$202M
$1K ﹤0.01%
144
IPSC icon
1250
Century Therapeutics
IPSC
$370M
$1K ﹤0.01%
159

Similar funds

Daiwa Securities Group's Q4 2022 Portfolio in Review

As of Q4 2022, Daiwa Securities Group held 1,449 positions worth $13B, up 8.2% from $12B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Daiwa Securities Group's Q4 2022 filing shows 52 new, 710 increased, 341 reduced and 132 closed positions. Its largest new stake was Atlassian: 9,371 shares worth $1.21M. The largest sale was Duke Realty Corp., an estimated $310M.

By sector, the portfolio is most concentrated in Real Estate at 58% of assets, down from 59% a quarter earlier, followed by Technology and Healthcare.

  • Daiwa Securities Group's largest Q4 2022 buy was Atlassian: 9,371 shares worth $1.21M.
  • Daiwa Securities Group added most to Prologis in Q4 2022, an estimated $287M increase.
  • Daiwa Securities Group's biggest Q4 2022 reduction was Simon Property Group, cutting an estimated $93.4M.
  • Daiwa Securities Group fully exited Duke Realty Corp. in Q4 2022, selling an estimated $310M.
  • Daiwa Securities Group's ten largest holdings make up 38% of its $13B portfolio in Q4 2022.
  • Daiwa Securities Group opened 52 new positions and closed 132 in Q4 2022.
  • Daiwa Securities Group's portfolio value rose 8.2% quarter-over-quarter to $13B.

Based on Daiwa Securities Group's 13F filing for Q4 2022, filed 6 Feb 2023.